Arrowstreet Capital’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $851K | Sell |
35,606
-31,982
| -47% | -$764K | ﹤0.01% | 1650 |
|
|
2025
Q1 | $1.68M | Sell |
67,588
-579,730
| -90% | -$14.4M | ﹤0.01% | 1353 |
|
|
2024
Q4 | $12.2M | Sell |
647,318
-505,307
| -44% | -$9.52M | 0.01% | 766 |
|
|
2024
Q3 | $17.3M | Buy |
1,152,625
+1,099,216
| +2,058% | +$16.5M | 0.01% | 574 |
|
|
2024
Q2 | $1.53M | Buy |
+53,409
| New | +$1.53M | ﹤0.01% | 1138 |
|
|
2017
Q3 | – | Sell |
-12,000
| Closed | -$572K | – | 1199 |
|
|
2017
Q2 | $572K | Buy |
+12,000
| New | +$572K | ﹤0.01% | 860 |
|
|
2015
Q1 | – | Sell |
-46,160
| Closed | -$4.09M | – | 1171 |
|
|
2014
Q4 | $4.09M | Sell |
46,160
-70,334
| -60% | -$6.24M | 0.02% | 501 |
|
|
2014
Q3 | $11.3M | Buy |
116,494
+90,908
| +355% | +$8.81M | 0.06% | 256 |
|
|
2014
Q2 | $2.35M | Buy |
+25,586
| New | +$2.35M | 0.01% | 549 |
|